Mirati-516: A Phase 1/1b Study of MGCD516 in Patients with Advanced Solid Tumor Malignancies

October 15, 2015
https://clinicaltrials.gov/ct2/show/NCT02219711
Cancer - Gastro/ Colorectal, Cancer - Genitourinary/ Prostate, Cancer - Lung
Principal Investigator: Ding Wang, MD
Solid tumors, gastrointestinal cancer, colorectal cancer, advanced cancer, metastatic cancer, renal cancer, NSCLC cancer, advanced solid tumors
Accepting Participants